{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:29:39Z","timestamp":1776472179960,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaapos.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T23:00:37Z","timestamp":1466982037000},"page":"337-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes"],"prefix":"10.1016","volume":"20","author":[{"given":"Emil Anthony T.","family":"Say","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth G.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Hasanreisoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara E.","family":"Lally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2016.05.009_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archopht.120.4.460","article-title":"Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ophtha.2004.04.016","article-title":"Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation","volume":"111","author":"G\u00fcnd\u00fcz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archopht.1958.00940080917010","article-title":"The treatment of retinoblastoma by X-ray and triethylene melamine","volume":"60","author":"Reese","year":"1958","journal-title":"AMA Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib7","first-page":"1829","article-title":"Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors","volume":"70","author":"Kiribuchi","year":"1966","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jaapos.2016.05.009_bib8","first-page":"289","article-title":"Chemotherapy was successful in two cases of recurrence of intraocular retinoblastoma after irradiation","volume":"44","author":"Kaneko","year":"1990","journal-title":"Rinsho Ganka"},{"key":"10.1016\/j.jaapos.2016.05.009_bib9","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A\u00a0phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/IAE.0b013e318203c101","article-title":"Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma","volume":"31","author":"Munier","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2016.05.009_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ophtha.2011.08.045","article-title":"Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma","volume":"119","author":"Muen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3171\/2012.5.PEDS1277","article-title":"Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma: a review","volume":"10","author":"Jabbour","year":"2012","journal-title":"J\u00a0Neurosurg Pediatrics"},{"key":"10.1016\/j.jaapos.2016.05.009_bib14","first-page":"858","article-title":"Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay","volume":"78","author":"Inomata","year":"1987","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.jaapos.2016.05.009_bib15","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.12-9501","article-title":"Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients","volume":"53","author":"Schaiquevich","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2016.05.009_bib16","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1248\/bpb.31.2126","article-title":"Evaluation of amino acid-mustard transport as l-type amino acid transporter 1 (LAT1)-mediated alkylating agents","volume":"31","author":"Hosaya","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jaapos.2016.05.009_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/IAE.0b013e31821e9f8a","article-title":"Pharmacokinetic analysis of topotecan after superselective ophthalmic artery infusion and periocular administration in a porcine model","volume":"32","author":"Schaiquevich","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2016.05.009_bib18","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-05-0849","article-title":"Topotecan combination chemotherapy in two new rodent models of retinoblastoma","volume":"11","author":"Laurie","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaapos.2016.05.009_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ophtha.2013.10.045","article-title":"Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma","volume":"121","author":"Taich","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ophtha.2011.06.036","article-title":"Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma","volume":"119","author":"Shields","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1755-3768.2011.02296.x","article-title":"Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments","volume":"91","author":"Venturi","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"130","author":"Ghassemi","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","article-title":"Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"132","author":"Ghassemi","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib26","first-page":"72","article-title":"Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease","volume":"19","author":"Matthew","year":"2015","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2016.05.009_bib27","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archophthalmol.2011.151","article-title":"Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2016.05.009_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ophtha.2011.09.040","article-title":"Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma","volume":"119","author":"Bianciotto","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2016.05.009_bib30","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archophthalmol.2011.223","article-title":"Histopathologic observations after intra-arterial chemotherapy for retinoblastoma","volume":"129","author":"Eagle","year":"2011","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853116301112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853116301112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:21:29Z","timestamp":1761078089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853116301112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1091853116301112"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2016.05.009","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 by the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}]}}